🇺🇸 CRYPTENAMINE TANNATES in United States

CRYPTENAMINE TANNATES (CRYPTENAMINE TANNATES) regulatory status in United States.

Marketing authorisations

FDA

  • Status: approved

FDA

  • Application: NDA009217
  • Marketing authorisation holder: MEDPOINTE PHARM HLC
  • Local brand name: UNITENSEN
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

CRYPTENAMINE TANNATES in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is CRYPTENAMINE TANNATES approved in United States?

Yes. FDA has authorised it; FDA has authorised it.

Who is the marketing authorisation holder for CRYPTENAMINE TANNATES in United States?

Marketing authorisation holder not available in our data.